Cite
HARVARD Citation
Liou, J. et al. (2010). Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design. Gut. 59 (5), pp. 572-578. [Online].